SCHEMBL16520792

SCHEMBL16520792

Cc1ccc(-c2nc(-c3cccnc3C)no2)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.59
▸ RAB9A P51151 7/20 0.59
▸ S1PR1 P21453 9/20 0.51
▸ MAPT P10636 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ PKM P14618 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ S1PR3 Q99500 1/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ NFKB2 Q00653 1/20 0.48
▸ RELA Q04206 1/20 0.48
▸ GAA P10253 1/20 0.46
▸ MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13525317 0.86 S1PR1 (0.65) NPC1RAB9AS1PR1MAPTTSHR
SCHEMBL16523151 0.85 S1PR1 (0.66) NPC1RAB9AS1PR1MAPTMEN1
SCHEMBL15730117 0.78 MKNK1 (0.51) NPC1
SCHEMBL2788271 0.76 S1PR1 (0.81) NPC1RAB9AS1PR1TP53TSHR
SCHEMBL14327874 0.76 S1PR1 (0.74) NPC1RAB9AS1PR1MAPTTP53
SCHEMBL14327886 0.76 S1PR1 (0.73) NPC1RAB9AS1PR1MAPTMEN1
SCHEMBL13197572 0.76 L3MBTL1 (0.49) NPC1RAB9AMAPTPKMTSHR
SCHEMBL23524193 0.75 HPGD (0.40) NPC1RAB9AS1PR1MAPTMEN1
SCHEMBL14327896 0.74 NPC1 (0.58) NPC1RAB9AS1PR1MAPTMEN1
SCHEMBL14329053 0.74 S1PR1 (0.74) NPC1RAB9AS1PR1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050941-A1 NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-02-23 — — US disclosed
US-9382217-B2 Modulators of sphingosine phosphate receptors THE SCRIPPS RESEARCH INSTITUTE (US) 2016-07-05 — — US disclosed
US-20150057307-A1 NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050941-A1 NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS S1PR1, S1PR3, S1PR2 NPC1 1349/4885RAB9A 2455/4885S1PR1 1/4885
US-20150057307-A1 NOVEL MODULATORS OF SPHINGOSINE PHOSPHATE RECEPTORS S1PR1, S1PR3, S1PR2 NPC1 1349/4885RAB9A 2455/4885S1PR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback